1 of 1
Story summary
- Keith Krehbiel, diagnosed with early-onset Parkinson's disease in 1997, is the first patient in a trial of an adaptive deep brain stimulation device.
- The device adjusts stimulation based on real-time brain signals.
- The FDA approved the adaptive deep brain stimulation device in February 2025.
- Dr. Helen Bronte-Stewart, the trial's lead investigator, says the device is not a cure but can improve quality of life.
